Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Aceragen, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 33 | 34 | +1 |
| Shares | 3.60M | 3.48M | −120.0K (−3.3%) |
| Value | $1.65M | $1.30M | −$349.2K (−21.2%) |
New holders (4)
Institutions that held Aceragen, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mariner, LLC | 12,312 | $5.00K | 0.00% |
| Susquehanna International Group, LLP | 14,432 | $5.00K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 10,082 | $3.78K | 0.00% |
| JPMorgan Chase & Co | 200 | $0 | 0.00% |
Sold out (3)
Institutions that held Aceragen, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citigroup Inc | 14,293 | $7.00K |
| Two Sigma Securities, LLC | 13,907 | $6.00K |
| Captrust Financial Advisors | 812 | $0 |